Cesarean Trial of Staples vs. Sutures (CROSS)

November 7, 2019 updated by: Thomas Jefferson University

Cesarean Randomized Control Trial Of Sutures vs. Staples (CROSS)

To determine whether the rate of wound complications differs based on method of closure of skin incision (staples vs. suture) after cesarean delivery.

Study Overview

Detailed Description

Despite this large number of cesareans performed annually, there is a paucity of data to suggest which technique is superior for closure of the skin incision with regards to wound complications, including wound separation and infection. As the morbidity associated with a cesarean delivery is usually related to wound complications, especially infection, we feel that it is important to examine this outcome by comparing the current skin closure techniques: staples versus suture.

Study Type

Interventional

Enrollment (Actual)

746

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • New Haven, Connecticut, United States
        • Yale University
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19107
        • Thomas Jefferson University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women undergoing cesarean delivery for pregnancy greater than 23 weeks gestation.

Exclusion Criteria:

  • Poorly controlled diabetes (defined as ≥ 50% of fasting or 2 hour postprandial glucose levels > 95 and 120 respectively within the week prior to delivery),
  • Vertical skin incisions
  • Chronic steroid use
  • Active lupus flare
  • HIV/AIDS
  • Current treatment for cancer or a history of radiation to the abdomen/pelvis
  • Current treatment with immunosuppressant medications secondary to history of transplantation
  • Emergency cesarean(precluding informed consent prior to surgery)
  • Lack of access to a phone
  • Allergy to suture or staple material

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Staples
Interrupted Ethicon Staples
Interrupted Ethicon Staples
Other Names:
  • Closure Technique
Active Comparator: Suture
Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)
Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)
Other Names:
  • Closure Technique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants With Wound Complications
Time Frame: Within 6 weeks of postpartum

The primary outcome is to evaluate the rate of wound complications for patients undergoing cesarean whose skin incision is closed with staples versus with suture.

Wound complications included infection, hematoma, seroma, and separation and readmission for wound complication.

Within 6 weeks of postpartum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Scar Assessment Scale Scores for Evaluation of Cosmesis
Time Frame: Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.

Patient evaluation of cosmesis of the cesarean incision based on closure method: staples vs sutures.

Surgical scars were evaluated using Patient Scar Assessment Scale (PSAS). The PSAS evaluates six items: pain, itchiness, color, stiffness, thickness, and irregularity. Each item is scored on a 10-point scale comparing the patient's skin to normal skin, in which one represents normal skin. The score is summed, range 6-60. Lower scores indicate closer resemblance to normal skin and are superior.

Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.
Patient Satisfaction With Closure Method and Scar Appearance
Time Frame: Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.
Whether the patient's satisfaction with the incision differed based on closure method (staples vs sutures) using 10-point Likert scale on which 1 is completely dissatisfied and 10 is completely satisfied.
Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.
Pain Perception
Time Frame: Immediately postpartum to time of discharge, which is typically 3-4 days post-cesarean
Whether the patient's perception of pain associated with the incision differed based on closure method (staples vs sutures). Patients were asked to rate pain on a scale from 0 (no pain) to 10 (extreme pain) using a visual graph of facial expressions.
Immediately postpartum to time of discharge, which is typically 3-4 days post-cesarean
Additional Provider Visits
Time Frame: Within 6 weeks postpartum
Mean number of visits per participant (All wound visits, number of visits for women who were diagnosed with wound complications, number of visits for women who were not diagnosed with a wound complication).
Within 6 weeks postpartum
Number of Participants With Primary Versus Repeat Cesarean
Time Frame: At randomization.
Randomization stratum - BMI (over/under 30) and Cesarean (primary or repeat)
At randomization.
Intraoperative Trial Details - Duration of Operation and Skin Closure
Time Frame: Time of Cesarean
Duration of operation: skin incision to skin closure Duration of skin closure: fascial closure to skin closure
Time of Cesarean
Intraoperative Trial Details - Closure of Subcutaneous Tissue
Time Frame: Time of Cesarean
Number of participants requiring subcutaneous tissue closure
Time of Cesarean
Length of Hospital Stay
Time Frame: Immediate postpartum.
Length of hospital stay (days)
Immediate postpartum.
Number of Participants That Received Anticoagulation Within 24 Hours
Time Frame: Within 24 hours postpartum.
Number of participants that received anticoagulation within 24 hours of procedure (preoperatively or postoperatively)
Within 24 hours postpartum.
Number of Participants Diagnosed With Endomyometritis
Time Frame: Immediate postpartum.
Number of participants diagnosed with endomyometritis requiring antibiotics
Immediate postpartum.
Change in Hemoglobin Pre-operatively to Post-operatively
Time Frame: Up to 72 hours before and 24 hours after cesarean.
Median change in hemoglobin from preoperative value (g/dL) to post-operatively.
Up to 72 hours before and 24 hours after cesarean.
Observer Evaluation of Cosmesis of the Cesarean Incision Based on Closure Method: Staples vs Sutures.
Time Frame: Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.
Surgical scars were evaluated using Observer Scar Assessment Scale (OSAS). The OSAS evaluates five items: vascularity, pigmentation, thickness, relief, and pliability. Each item is scored on a 10-point scale comparing the patient's skin to normal skin, in which one represents normal skin. The score is summed, range 5-50. Lower scores indicate closer resemblance to normal skin and are superior.
Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: A. Dhanya Mackeen, MD, MPH, Thomas Jefferson University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2010

Primary Completion (Actual)

October 1, 2014

Study Completion (Actual)

December 1, 2014

Study Registration Dates

First Submitted

September 28, 2010

First Submitted That Met QC Criteria

September 28, 2010

First Posted (Estimate)

September 29, 2010

Study Record Updates

Last Update Posted (Actual)

November 26, 2019

Last Update Submitted That Met QC Criteria

November 7, 2019

Last Verified

November 1, 2019

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarean Section

Clinical Trials on Staples

3
Subscribe